Clinical Trials Market Future Challenges and Industry Growth Outlook 2030
Global Market Insights recently introduced report on Global Clinical Trials Market Report is an in-depth study providing complete analysis of the industry for the period 2022 to 2030. It provides complete overview of Global Clinical Trials industry considering all the major industry trends, market dynamics and competitive scenario.
During the COVID-19 pandemic, restrictions on movement and various discrepancies in the healthcare sector posed a threat to market growth. Many clinical trial projects were either halted or postponed in light of the implications of COVID-19. However, ease in lockdown restrictions and declining cases across key regions have been favorable for the business scenario. Government funding and grants for clinical trials have also pushed healthcare companies to outsource clinical trials to CROs.
Browse key industry insights spread across 150 pages with 208 market data tables & 16 figures & charts from the report, “Clinical Trials Market Analysis By Phases (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Study, Observational Study, Expanded Access Study), By Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology) Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/clinical-trials-market
Additionally, major players in the industry have been focusing on new service launches and growth strategies like collaborations and partnerships to improve their standing in the competitive landscape. For instance, in February 2021, LabCorp, also known as Laboratory Corporation of America Holdings, a life sciences company, collaborated with Circuit Clinical, an American integrated research organization, to bring clinical trials to provide direct access to underrepresented patients. The collaboration was intended to give a broad and diverse patient population, who are otherwise neglected, the opportunity to participate in clinical trials.
To cite another instance, in April 2021, Bioclinica, a clinical trial service provider, introduced its new source document management solution integrated with advanced software and redaction & translation services to back global research site and trial management.
In another instance, in February 2021, ICON, a global clinical research organization, acquired PRA Health Sciences, a key participant in the market, for approximately $12 billion. The deal brought together the two firms that have a shared focus on high-quality and efficient clinical trial execution.
The clinical trials market has been segmented in terms of therapeutic area, phase, study design, and region. On the basis of phase, the clinical trials market has been divided into phase I, phase II, phase III, and phase IV. The phase I segment accounted for above $8,450.1 million in revenue in 2021.
Partial Table of Contents (ToC) of the report:
Chapter 4 Clinical Trials Market, By Phase
4.1 Key segment trends
4.2 Phase I
4.2.1 Market size, by region, 2017-2030 (USD Million)
4.3 Phase II
4.3.1 Market size, by region, 2017-2030 (USD Million)
4.4 Phase III
4.4.1 Market size, by region, 2017-2030 (USD Million)
4.5 Phase IV
4.5.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Clinical Trials Market, By Study Design
5.1 Key segment trend
5.2 Interventional study
5.2.1 Market size, by region, 2017-2030 (USD Million)
5.3 Observational study
5.3.1 Market size, by region, 2017-2030 (USD Million)
5.4 Expanded access study
5.4.1 Market size, by region, 2017-2030 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/clinical-trials-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us
Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com